Doug Laidlaw, PhD is the Senior Director, Medical Affairs of Talaris Therapeutics. Doug has 20 years of Medical Affairs experience in the biopharmaceutical industry. Prior to joining Talaris, Doug served as Founder and President of Summit Scientific Consulting, providing Medical Affairs, Clinical Development and precision genetic testing workflow optimization consulting services. Doug previously held positions of increasing responsibility in Medical Affairs at Genzyme/Sanofi, Keryx Biopharmaceuticals, Relypsa, Pancreatic Cancer Action Network, Opko Health, Audentes Therapeutics and Reata Pharmaceuticals. His early career included Medical Affairs positions with several established biopharmaceutical companies such as Organon Pharmaceuticals, Serono and Neurocrine Biosciences. Doug received his B.A. (Health Sciences) from Sonoma State University and M.S. (Exercise & Sport Sciences) and Ph.D. (Physiological Sciences) from the University of Arizona.